Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) Revenue
Annual & quarterly revenue history · segment & region breakdown
GZPHF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited trailing twelve-month (TTM) revenue is $77.99B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare GZPHF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GZPHF revenue · 4 questionsGZPHF's trailing twelve-month (TTM) revenue is $77.99B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited SEC filings · GAAP · Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026